XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Condensed Consolidating Financial Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2018
Condensed Financial Information Disclosure [Abstract] |
Condensed Consolidating Statement of Operations |
| Three Months Ended June 30, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.7 |  |  | $ | 581.5 |  |  | $ | 513.7 |  |  | $ | (33.2 | ) |  | $ | 1,067.7 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 9.4 |  |  | 277.7 |  |  | 296.5 |  |  | (5.4 | ) |  | 578.2 |
Other operating expenses | 9.3 |  |  | 89.8 |  |  | 63.3 |  |  | (13.0 | ) |  | 149.4 |
Occupancy costs | 0.5 |  |  | 23.9 |  |  | 9.9 |  |  | (14.8 | ) |  | 19.5 |
Supplies | — |  |  | 23.5 |  |  | 15.8 |  |  | — |  |  | 39.3 |
General and administrative expenses | 41.2 |  |  | — |  |  | 13.7 |  |  | — |  |  | 54.9 |
Depreciation and amortization | 3.5 |  |  | 26.7 |  |  | 19.5 |  |  | — |  |  | 49.7 |
Total operating expenses | 63.9 |  |  | 441.6 |  |  | 418.7 |  |  | (33.2 | ) |  | 891.0 |
Interest expense and amortization of debt discounts and fees | 31.9 |  |  | 5.2 |  |  | 7.2 |  |  | (6.6 | ) |  | 37.7 |
Other income | (6.2 | ) |  | (0.3 | ) |  | (1.4 | ) |  | 6.6 |  |  | (1.3 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (1.7 | ) |  | (0.3 | ) |  | — |  |  | (2.0 | )
Equity in net income of consolidated affiliates | (117.4 | ) |  | (17.6 | ) |  | — |  |  | 135.0 |  |  | — |
Management fees | (38.5 | ) |  | 28.1 |  |  | 10.4 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 72.0 |  |  | 126.2 |  |  | 79.1 |  |  | (135.0 | ) |  | 142.3 |
Provision for income tax (benefit) expense | (19.6 | ) |  | 34.0 |  |  | 14.9 |  |  | — |  |  | 29.3 |
Income from continuing operations | 91.6 |  |  | 92.2 |  |  | 64.2 |  |  | (135.0 | ) |  | 113.0 |
Income from discontinued operations, net of tax | 0.2 |  |  | — |  |  | — |  |  | — |  |  | 0.2 |
Net income | 91.8 |  |  | 92.2 |  |  | 64.2 |  |  | (135.0 | ) |  | 113.2 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (21.4 | ) |  | — |  |  | (21.4 | )
Net income attributable to Encompass Health | $ | 91.8 |  |  | $ | 92.2 |  |  | $ | 42.8 |  |  | $ | (135.0 | ) |  | $ | 91.8 |
Comprehensive income | $ | 91.8 |  |  | $ | 92.2 |  |  | $ | 64.2 |  |  | $ | (135.0 | ) |  | $ | 113.2 |
Comprehensive income attributable to Encompass Health | $ | 91.8 |  |  | $ | 92.2 |  |  | $ | 42.8 |  |  | $ | (135.0 | ) |  | $ | 91.8 |
| Three Months Ended June 30, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.3 |  |  | $ | 558.4 |  |  | $ | 434.3 |  |  | $ | (31.6 | ) |  | $ | 966.4 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 8.7 |  |  | 267.1 |  |  | 257.2 |  |  | (5.2 | ) |  | 527.8 |
Other operating expenses | 7.5 |  |  | 78.9 |  |  | 55.0 |  |  | (12.1 | ) |  | 129.3 |
Occupancy costs | 0.5 |  |  | 23.3 |  |  | 8.8 |  |  | (14.3 | ) |  | 18.3 |
Supplies | — |  |  | 23.4 |  |  | 13.7 |  |  | — |  |  | 37.1 |
General and administrative expenses | 37.6 |  |  | — |  |  | 14.8 |  |  | — |  |  | 52.4 |
Depreciation and amortization | 2.4 |  |  | 25.7 |  |  | 17.7 |  |  | — |  |  | 45.8 |
Total operating expenses | 56.7 |  |  | 418.4 |  |  | 367.2 |  |  | (31.6 | ) |  | 810.7 |
Loss on early extinguishment of debt | 10.4 |  |  | — |  |  | — |  |  | — |  |  | 10.4 |
Interest expense and amortization of debt discounts and fees | 34.5 |  |  | 5.3 |  |  | 5.9 |  |  | (5.3 | ) |  | 40.4 |
Other income | (5.4 | ) |  | (0.1 | ) |  | (0.7 | ) |  | 5.3 |  |  | (0.9 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (1.8 | ) |  | (0.2 | ) |  | — |  |  | (2.0 | )
Equity in net income of consolidated affiliates | (85.2 | ) |  | (7.7 | ) |  | — |  |  | 92.9 |  |  | — |
Management fees | (36.1 | ) |  | 27.1 |  |  | 9.0 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 30.4 |  |  | 117.2 |  |  | 53.1 |  |  | (92.9 | ) |  | 107.8 |
Provision for income tax (benefit) expense | (32.4 | ) |  | 46.8 |  |  | 14.2 |  |  | — |  |  | 28.6 |
Income from continuing operations | 62.8 |  |  | 70.4 |  |  | 38.9 |  |  | (92.9 | ) |  | 79.2 |
Income from discontinued operations, net of tax | 0.2 |  |  | — |  |  | — |  |  | — |  |  | 0.2 |
Net income | 63.0 |  |  | 70.4 |  |  | 38.9 |  |  | (92.9 | ) |  | 79.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (16.4 | ) |  | — |  |  | (16.4 | )
Net income attributable to Encompass Health | $ | 63.0 |  |  | $ | 70.4 |  |  | $ | 22.5 |  |  | $ | (92.9 | ) |  | $ | 63.0 |
Comprehensive income | $ | 63.0 |  |  | $ | 70.4 |  |  | $ | 38.9 |  |  | $ | (92.9 | ) |  | $ | 79.4 |
Comprehensive income attributable to Encompass Health | $ | 63.0 |  |  | $ | 70.4 |  |  | $ | 22.5 |  |  | $ | (92.9 | ) |  | $ | 63.0 |
| Six Months Ended June 30, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 11.1 |  |  | $ | 1,168.5 |  |  | $ | 999.9 |  |  | $ | (65.8 | ) |  | $ | 2,113.7 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 22.6 |  |  | 556.9 |  |  | 579.7 |  |  | (10.8 | ) |  | 1,148.4 |
Other operating expenses | 17.7 |  |  | 173.5 |  |  | 124.8 |  |  | (25.4 | ) |  | 290.6 |
Occupancy costs | 1.0 |  |  | 47.6 |  |  | 19.1 |  |  | (29.6 | ) |  | 38.1 |
Supplies | — |  |  | 47.9 |  |  | 31.3 |  |  | — |  |  | 79.2 |
General and administrative expenses | 80.6 |  |  | — |  |  | 35.4 |  |  | — |  |  | 116.0 |
Depreciation and amortization | 5.5 |  |  | 52.8 |  |  | 37.3 |  |  | — |  |  | 95.6 |
Total operating expenses | 127.4 |  |  | 878.7 |  |  | 827.6 |  |  | (65.8 | ) |  | 1,767.9 |
Interest expense and amortization of debt discounts and fees | 61.7 |  |  | 10.4 |  |  | 12.9 |  |  | (11.7 | ) |  | 73.3 |
Other income | (10.9 | ) |  | (0.5 | ) |  | (1.5 | ) |  | 11.7 |  |  | (1.2 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (3.6 | ) |  | (0.7 | ) |  | — |  |  | (4.3 | )
Equity in net income of consolidated affiliates | (229.4 | ) |  | (35.4 | ) |  | — |  |  | 264.8 |  |  | — |
Management fees | (76.9 | ) |  | 56.5 |  |  | 20.4 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 139.2 |  |  | 262.4 |  |  | 141.2 |  |  | (264.8 | ) |  | 278.0 |
Provision for income tax (benefit) expense | (36.7 | ) |  | 70.7 |  |  | 25.3 |  |  | — |  |  | 59.3 |
Income from continuing operations | 175.9 |  |  | 191.7 |  |  | 115.9 |  |  | (264.8 | ) |  | 218.7 |
Loss from discontinued operations, net of tax | (0.3 | ) |  | — |  |  | — |  |  | — |  |  | (0.3 | )
Net income | 175.6 |  |  | 191.7 |  |  | 115.9 |  |  | (264.8 | ) |  | 218.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (42.8 | ) |  | — |  |  | (42.8 | )
Net income attributable to Encompass Health | $ | 175.6 |  |  | $ | 191.7 |  |  | $ | 73.1 |  |  | $ | (264.8 | ) |  | $ | 175.6 |
Comprehensive income | $ | 175.6 |  |  | $ | 191.7 |  |  | $ | 115.9 |  |  | $ | (264.8 | ) |  | $ | 218.4 |
Comprehensive income attributable to Encompass Health | $ | 175.6 |  |  | $ | 191.7 |  |  | $ | 73.1 |  |  | $ | (264.8 | ) |  | $ | 175.6 |
| Six Months Ended June 30, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 10.6 |  |  | $ | 1,119.1 |  |  | $ | 856.6 |  |  | $ | (62.8 | ) |  | $ | 1,923.5 |
Operating expenses: |  |  |  |  |  |  |  |  |
Salaries and benefits | 19.9 |  |  | 537.4 |  |  | 511.1 |  |  | (10.5 | ) |  | 1,057.9 |
Other operating expenses | 15.7 |  |  | 155.8 |  |  | 109.6 |  |  | (24.0 | ) |  | 257.1 |
Occupancy costs | 1.0 |  |  | 46.6 |  |  | 16.9 |  |  | (28.3 | ) |  | 36.2 |
Supplies | — |  |  | 46.9 |  |  | 27.2 |  |  | — |  |  | 74.1 |
General and administrative expenses | 69.2 |  |  | — |  |  | 19.7 |  |  | — |  |  | 88.9 |
Depreciation and amortization | 4.8 |  |  | 51.4 |  |  | 34.8 |  |  | — |  |  | 91.0 |
Total operating expenses | 110.6 |  |  | 838.1 |  |  | 719.3 |  |  | (62.8 | ) |  | 1,605.2 |
Loss on early extinguishment of debt | 10.4 |  |  | — |  |  | — |  |  | — |  |  | 10.4 |
Interest expense and amortization of debt discounts and fees | 69.7 |  |  | 10.7 |  |  | 11.7 |  |  | (10.4 | ) |  | 81.7 |
Other income | (10.8 | ) |  | (0.2 | ) |  | (1.3 | ) |  | 10.4 |  |  | (1.9 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (3.7 | ) |  | (0.4 | ) |  | — |  |  | (4.1 | )
Equity in net income of consolidated affiliates | (171.4 | ) |  | (17.5 | ) |  | — |  |  | 188.9 |  |  | — |
Management fees | (72.0 | ) |  | 54.2 |  |  | 17.8 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 74.1 |  |  | 237.5 |  |  | 109.5 |  |  | (188.9 | ) |  | 232.2 |
Provision for income tax (benefit) expense | (55.8 | ) |  | 94.8 |  |  | 29.3 |  |  | — |  |  | 68.3 |
Income from continuing operations | 129.9 |  |  | 142.7 |  |  | 80.2 |  |  | (188.9 | ) |  | 163.9 |
Loss from discontinued operations, net of tax | (0.1 | ) |  | — |  |  | — |  |  | — |  |  | (0.1 | )
Net income | 129.8 |  |  | 142.7 |  |  | 80.2 |  |  | (188.9 | ) |  | 163.8 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (34.0 | ) |  | — |  |  | (34.0 | )
Net income attributable to Encompass Health | $ | 129.8 |  |  | $ | 142.7 |  |  | $ | 46.2 |  |  | $ | (188.9 | ) |  | $ | 129.8 |
Comprehensive income | $ | 130.1 |  |  | $ | 142.7 |  |  | $ | 80.2 |  |  | $ | (188.9 | ) |  | $ | 164.1 |
Comprehensive income attributable to Encompass Health | $ | 130.1 |  |  | $ | 142.7 |  |  | $ | 46.2 |  |  | $ | (188.9 | ) |  | $ | 130.1 |
Condensed Consolidating Balance Sheet |
| As of June 30, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 34.2 |  |  | $ | 3.9 |  |  | $ | 20.9 |  |  | $ | — |  |  | $ | 59.0 |
Restricted cash | — |  |  | — |  |  | 65.8 |  |  | — |  |  | 65.8 |
Accounts receivable | — |  |  | 268.2 |  |  | 188.4 |  |  | — |  |  | 456.6 |
Other current assets | 76.4 |  |  | 17.1 |  |  | 60.7 |  |  | (64.0 | ) |  | 90.2 |
Total current assets | 110.6 |  |  | 289.2 |  |  | 335.8 |  |  | (64.0 | ) |  | 671.6 |
Property and equipment, net | 120.6 |  |  | 1,007.1 |  |  | 438.1 |  |  | — |  |  | 1,565.8 |
Goodwill | — |  |  | 854.6 |  |  | 1,220.1 |  |  | — |  |  | 2,074.7 |
Intangible assets, net | 21.9 |  |  | 102.3 |  |  | 319.2 |  |  | — |  |  | 443.4 |
Deferred income tax assets | 106.8 |  |  | 8.4 |  |  | — |  |  | (39.8 | ) |  | 75.4 |
Other long-term assets | 51.2 |  |  | 103.4 |  |  | 103.9 |  |  | — |  |  | 258.5 |
Intercompany notes receivable | 589.4 |  |  | — |  |  | — |  |  | (589.4 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,844.9 |  |  | 577.1 |  |  | — |  |  | (3,422.0 | ) |  | — |
Total assets | $ | 3,845.4 |  |  | $ | 2,942.1 |  |  | $ | 2,417.1 |  |  | $ | (4,115.2 | ) |  | $ | 5,089.4 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 34.5 |  |  | $ | 7.7 |  |  | $ | 11.3 |  |  | $ | (17.5 | ) |  | $ | 36.0 |
Accounts payable | 12.7 |  |  | 47.6 |  |  | 25.3 |  |  | — |  |  | 85.6 |
Accrued expenses and other current liabilities | 190.2 |  |  | 66.4 |  |  | 242.2 |  |  | (46.5 | ) |  | 452.3 |
Total current liabilities | 237.4 |  |  | 121.7 |  |  | 278.8 |  |  | (64.0 | ) |  | 573.9 |
Long-term debt, net of current portion | 2,318.3 |  |  | 238.1 |  |  | 44.1 |  |  | — |  |  | 2,600.5 |
Intercompany notes payable | — |  |  | — |  |  | 589.4 |  |  | (589.4 | ) |  | — |
Other long-term liabilities | 34.8 |  |  | 17.1 |  |  | 177.6 |  |  | (39.7 | ) |  | 189.8 |
Intercompany payable | — |  |  | — |  |  | 80.3 |  |  | (80.3 | ) |  | — |
| 2,590.5 |  |  | 376.9 |  |  | 1,170.2 |  |  | (773.4 | ) |  | 3,364.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 223.9 |  |  | — |  |  | 223.9 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,254.9 |  |  | 2,565.2 |  |  | 776.6 |  |  | (3,341.8 | ) |  | 1,254.9 |
Noncontrolling interests | — |  |  | — |  |  | 246.4 |  |  | — |  |  | 246.4 |
Total shareholders’ equity | 1,254.9 |  |  | 2,565.2 |  |  | 1,023.0 |  |  | (3,341.8 | ) |  | 1,501.3 |
Total liabilities and shareholders’ equity | $ | 3,845.4 |  |  | $ | 2,942.1 |  |  | $ | 2,417.1 |  |  | $ | (4,115.2 | ) |  | $ | 5,089.4 |
| As of December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Accounts receivable | — |  |  | 285.2 |  |  | 186.9 |  |  | — |  |  | 472.1 |
Other current assets | 61.4 |  |  | 21.7 |  |  | 48.7 |  |  | (18.5 | ) |  | 113.3 |
Total current assets | 95.7 |  |  | 309.8 |  |  | 315.2 |  |  | (18.5 | ) |  | 702.2 |
Property and equipment, net | 101.8 |  |  | 991.5 |  |  | 423.8 |  |  | — |  |  | 1,517.1 |
Goodwill | — |  |  | 854.6 |  |  | 1,118.0 |  |  | — |  |  | 1,972.6 |
Intangible assets, net | 11.8 |  |  | 105.1 |  |  | 286.2 |  |  | — |  |  | 403.1 |
Deferred income tax assets | 97.4 |  |  | 8.4 |  |  | — |  |  | (42.2 | ) |  | 63.6 |
Other long-term assets | 49.2 |  |  | 100.5 |  |  | 85.4 |  |  | — |  |  | 235.1 |
Intercompany notes receivable | 486.2 |  |  | — |  |  | — |  |  | (486.2 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,839.1 |  |  | 311.3 |  |  | — |  |  | (3,150.4 | ) |  | — |
Total assets | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 32.8 |  |  | $ | 7.4 |  |  | $ | 9.6 |  |  | $ | (17.5 | ) |  | $ | 32.3 |
Accounts payable | 10.4 |  |  | 43.5 |  |  | 24.5 |  |  | — |  |  | 78.4 |
Accrued expenses and other current liabilities | 166.8 |  |  | 82.0 |  |  | 159.0 |  |  | (1.0 | ) |  | 406.8 |
Total current liabilities | 210.0 |  |  | 132.9 |  |  | 193.1 |  |  | (18.5 | ) |  | 517.5 |
Long-term debt, net of current portion | 2,258.5 |  |  | 242.2 |  |  | 44.7 |  |  | — |  |  | 2,545.4 |
Intercompany notes payable | — |  |  | — |  |  | 486.2 |  |  | (486.2 | ) |  | — |
Other long-term liabilities | 31.0 |  |  | 17.8 |  |  | 178.6 |  |  | (42.1 | ) |  | 185.3 |
Intercompany payable | — |  |  | — |  |  | 144.8 |  |  | (144.8 | ) |  | — |
| 2,499.5 |  |  | 392.9 |  |  | 1,047.4 |  |  | (691.6 | ) |  | 3,248.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 220.9 |  |  | — |  |  | 220.9 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 717.4 |  |  | (3,005.7 | ) |  | 1,181.7 |
Noncontrolling interests | — |  |  | — |  |  | 242.9 |  |  | — |  |  | 242.9 |
Total shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 960.3 |  |  | (3,005.7 | ) |  | 1,424.6 |
Total liabilities and shareholders’ equity | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
Condensed Consolidating Statement of Cash Flows |
| Six Months Ended June 30, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash (used in) provided by operating activities | $ | (13.8 | ) |  | $ | 219.5 |  |  | $ | 179.8 |  |  | $ | — |  |  | $ | 385.5 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (18.0 | ) |  | (60.6 | ) |  | (30.2 | ) |  | — |  |  | (108.8 | )
Additions to capitalized software costs | (8.7 | ) |  | — |  |  | (1.0 | ) |  | — |  |  | (9.7 | )
Acquisitions of businesses, net of cash acquired | (129.7 | ) |  | — |  |  | (6.1 | ) |  | — |  |  | (135.8 | )
Proceeds from repayment of intercompany note receivable | 30.0 |  |  | — |  |  | — |  |  | (30.0 | ) |  | — |
Other, net | (5.2 | ) |  | (0.1 | ) |  | (1.4 | ) |  | — |  |  | (6.7 | )
Net cash used in investing activities | (131.6 | ) |  | (60.7 | ) |  | (38.7 | ) |  | (30.0 | ) |  | (261.0 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (7.6 | ) |  | — |  |  | (1.5 | ) |  | — |  |  | (9.1 | )
Principal payments on intercompany note payable | — |  |  | — |  |  | (30.0 | ) |  | 30.0 |  |  | — |
Borrowings on revolving credit facility | 245.0 |  |  | — |  |  | — |  |  | — |  |  | 245.0 |
Payments on revolving credit facility | (190.0 | ) |  | — |  |  | — |  |  | — |  |  | (190.0 | )
Dividends paid on common stock | (49.8 | ) |  | — |  |  | (0.1 | ) |  | — |  |  | (49.9 | )
Purchase of equity interests in consolidated affiliates | (65.1 | ) |  | — |  |  | — |  |  | — |  |  | (65.1 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (35.2 | ) |  | — |  |  | (35.2 | )
Taxes paid on behalf of employees for shares withheld | (7.4 | ) |  | — |  |  | (0.9 | ) |  | — |  |  | (8.3 | )
Other, net | 0.5 |  |  | (3.7 | ) |  | (0.7 | ) |  | — |  |  | (3.9 | )
Change in intercompany advances | 219.7 |  |  | (154.1 | ) |  | (65.6 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities | 145.3 |  |  | (157.8 | ) |  | (134.0 | ) |  | 30.0 |  |  | (116.5 | )
(Decrease) increase in cash, cash equivalents, and restricted cash | (0.1 | ) |  | 1.0 |  |  | 7.1 |  |  | — |  |  | 8.0 |
Cash, cash equivalents, and restricted cash at beginning of period | 34.3 |  |  | 2.9 |  |  | 79.6 |  |  | — |  |  | 116.8 |
Cash, cash equivalents, and restricted cash at end of period | $ | 34.2 |  |  | $ | 3.9 |  |  | $ | 86.7 |  |  | $ | — |  |  | $ | 124.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at beginning of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 79.6 |  |  | $ | — |  |  | $ | 116.8 |
Cash and cash equivalents at end of period | $ | 34.2 |  |  | $ | 3.9 |  |  | $ | 20.9 |  |  | $ | — |  |  | $ | 59.0 |
Restricted cash at end of period | — |  |  | — |  |  | 65.8 |  |  | — |  |  | 65.8 |
Cash, cash equivalents, and restricted cash at end of period | $ | 34.2 |  |  | $ | 3.9 |  |  | $ | 86.7 |  |  | $ | — |  |  | $ | 124.8 |
Supplemental schedule of noncash financing activity: |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (134.2 | ) |  | $ | — |  |  | $ | 134.2 |  |  | $ | — |  |  | $ | — |
| Six Months Ended June 30, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 26.8 |  |  | $ | 169.9 |  |  | $ | 135.3 |  |  | $ | — |  |  | $ | 332.0 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (13.1 | ) |  | (39.7 | ) |  | (47.1 | ) |  | — |  |  | (99.9 | )
Additions to capitalized software costs | (8.3 | ) |  | (0.2 | ) |  | (1.2 | ) |  | — |  |  | (9.7 | )
Acquisitions of businesses, net of cash acquired | (10.9 | ) |  | — |  |  | (10.0 | ) |  | — |  |  | (20.9 | )
Proceeds from repayment of intercompany note receivable | 17.0 |  |  | — |  |  | — |  |  | (17.0 | ) |  | — |
Other, net | (1.7 | ) |  | 9.0 |  |  | 3.7 |  |  | — |  |  | 11.0 |
Net cash used in investing activities | (17.0 | ) |  | (30.9 | ) |  | (54.6 | ) |  | (17.0 | ) |  | (119.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (11.9 | ) |  | — |  |  | (1.5 | ) |  | — |  |  | (13.4 | )
Principal payments on intercompany note payable | — |  |  | — |  |  | (17.0 | ) |  | 17.0 |  |  | — |
Borrowings on revolving credit facility | 105.0 |  |  | — |  |  | — |  |  | — |  |  | 105.0 |
Payments on revolving credit facility | (187.0 | ) |  | — |  |  | — |  |  | — |  |  | (187.0 | )
Repurchases of common stock, including fees and expenses | (18.1 | ) |  | — |  |  | — |  |  | — |  |  | (18.1 | )
Dividends paid on common stock | (43.5 | ) |  | — |  |  | — |  |  | — |  |  | (43.5 | )
Proceeds from exercising stock warrants | 26.6 |  |  | — |  |  | — |  |  | — |  |  | 26.6 |
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (24.1 | ) |  | — |  |  | (24.1 | )
Taxes paid on behalf of employees for shares withheld | (19.5 | ) |  | — |  |  | (0.3 | ) |  | — |  |  | (19.8 | )
Other, net | 0.4 |  |  | (3.3 | ) |  | 7.4 |  |  | — |  |  | 4.5 |
Change in intercompany advances | 158.4 |  |  | (133.4 | ) |  | (25.0 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities | 10.4 |  |  | (136.7 | ) |  | (60.5 | ) |  | 17.0 |  |  | (169.8 | )
Increase in cash, cash equivalents, and restricted cash | 20.2 |  |  | 2.3 |  |  | 20.2 |  |  | — |  |  | 42.7 |
Cash, cash equivalents, and restricted cash at beginning of period | 20.6 |  |  | 1.6 |  |  | 79.2 |  |  | — |  |  | 101.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 40.8 |  |  | $ | 3.9 |  |  | $ | 99.4 |  |  | $ | — |  |  | $ | 144.1 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 18.3 |  |  | $ | — |  |  | $ | 40.5 |
Restricted cash at beginning of period | — |  |  | — |  |  | 60.9 |  |  | — |  |  | 60.9 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 79.2 |  |  | $ | — |  |  | $ | 101.4 |
Cash and cash equivalents at end of period | $ | 40.8 |  |  | $ | 3.9 |  |  | $ | 26.4 |  |  | $ | — |  |  | $ | 71.1 |
Restricted cash at end of period | — |  |  | — |  |  | 73.0 |  |  | — |  |  | 73.0 |
Cash, cash equivalents, and restricted cash at end of period | $ | 40.8 |  |  | $ | 3.9 |  |  | $ | 99.4 |  |  | $ | — |  |  | $ | 144.1 |
Supplemental schedule of noncash financing activity: |  |  |  |  |  |  |  |  |
Conversion of convertible debt | $ | 319.4 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 319.4 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration